News & Events

View

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

23 October 2022

amplimark-2

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

18 October 2022

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

26 September 2022

Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis

Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy

Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting

Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay

Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA

10 January 2022

1
2
3

Lucence Shares Promising Interim Data from Prospective LIQUIK Study at ISLB 2022 .

>